🩸 Today is World Diabetes Day.

World Diabetes Day was established in 1991 by the World Health Organization (WHO) and the International Diabetes Federation (IDF).

November 14 marks the birthday of Frederick Banting, the scientist who discovered insulin — a breakthrough that became a historic turning point in humanity’s ability to control diabetes.

Recent studies show that excessive fat accumulation inside skeletal muscle is closely associated with diabetes. When fat builds up within muscle tissue, insulin sensitivity decreases, making blood glucose regulation more difficult.

These internal changes cannot be identified through body weight or appearance alone. This is why CT-based analysis, which allows clinicians to directly assess the ratio of muscle to fat inside the body, is so important.

At PROMEDIUS, we leverage AI to help clinicians evaluate these physiological changes more easily and more accurately.

Our AI automatically analyzes L3-level abdominal CT scans, quantifies the distribution of muscle and fat, and visualizes the results as meaningful indicators — enabling early detection of signals that may precede disease.

Identifying early warning signs and signaling them to clinicians and patients

is what PROMEDIUS does best.

PROMEDIUS is committed to its mission,

“Healthy Aging through AI.”

We are building an AI-powered preventive healthcare ecosystem that detects early risks of invisible aging and metabolic diseases — including osteoporosis and sarcopenia — and delivers timely Signals that guide better decisions for healthier aging.

[References]

1. Miljkovic, I., Kuipers, A. L., Cauley, J. A., Prasad, T., Lee, C. G., Ensrud, K. E., Cawthon, P. M., Koster, A., Cummings, S. R., Tylavsky, F. A., Goodpaster, B. H., Visser, M., & Newman, A. B. (2016).

Myosteatosis increases with aging and is associated with incident diabetes in African ancestry men.

Obesity (Silver Spring), 24(2), 476–482.

2. Kim, H. K., Kim, S. H., Kim, B. J., Kang, J. H., Lee, J. Y., & Lee, S. H. (2021).

Myosteatosis and metabolic disorders: The emerging role of skeletal muscle quality in metabolic health.

Endocrinology and Metabolism (Seoul), 36(3), 491–503.

3. Jung, M., Park, S., Kim, H. S., & Kim, T. N. (2024).

Association between myosteatosis and impaired glucose metabolism: Insights from body composition analysis using computed tomography.

Journal of Cachexia, Sarcopenia and Muscle, 15(2), 402–412.

4. Addison, O., Marcus, R. L., Lastayo, P. C., & Ryan, A. S. (2014).

Intermuscular fat: A review of the consequences and causes.

International Journal of Endocrinology, 2014, 309570.